Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bone Therapeutics
Biotech
Bone Therapeutics' final asset buried after phase 2 fail
Bone Therapeutics may have escaped the graveyard thanks to a buyout by Medsenic, but the merged company remains haunted by clinical difficulties.
James Waldron
Jun 19, 2023 6:49am
The 2022 Biotech Graveyard
Nov 21, 2022 3:00am
Orthopedics biotech finds a Bone in Medsenic reverse merger
Aug 10, 2022 9:16am
Bone breaks from original cell therapy plan, switching endpoint
Jul 15, 2022 8:25am
John Mascola moves on from NIAID's R&D hub—Chutes and Ladders
Apr 1, 2022 9:30am
Layoff surge hits 3 more biotechs
Mar 31, 2022 6:48pm
